Clinical effect of Jiawei Xiaoyao Powder in the treatment of depression with liver stagnation and spleen deficiency
YUAN Jinmin1 PEI Qinghua2 QU Miao2 ZHENG Qin2
1.The Third School of Clinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China;
2.Department of Encephalopathy, the Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing 100029, China
Abstract：Objective To observe the clinical effect of Jiawei Xiaoyao Powder in the treatment of depression with liver stagnation and spleen deficiency. Methods A total of 72 patients with mild to moderate depression of liver stagnation and spleen deficiency type admitted to the Third School of Clinical Medicine of Beijing University of Chinese Medicine from August 2020 to June 2021 were selected, according to the random number table method, they were divided into experimental group and control group, with 36 cases in each group. The experimental group was given internal application of Jiawei Xiaoyao Powder combined with Fluoxetine, and the control group was given internal application of the western medicine Fluoxetine, both of which were treated for four consecutive weeks. The antidepressant treatment effect, Hamilton depression scale (HAMD) score, traditional Chinese medicine syndrome score, and HAMD factor scores were compared between the two groups, and adverse events during the treatment were recorded. Results After treatment, the antidepressant treatment effect of the experimental group was better than that of the control group (P ＜ 0.05). Overall analysis showed that the total score of HAMD and the total score of traditional Chinese medicine syndrome had statistical significance in the comparison of time points and the difference of interaction (P ＜ 0.05). After 2 and 4 weeks of treatment, the total HAMD score and traditional Chinese medicine syndrome score of the two groups were lower than those before treatment (P ＜ 0.05). After treatment, the scores of all factors in the experimental group were better than those before treatment, while the scores of anxiety/somatization, cognitive impairment, day/night variation, delay/block, sleep disorder and hopelessness in the control group were better than those before treatment, and the scores of anxiety/somatization and sleep disorder in the experimental group were better than those in the control group (P ＜ 0.05). There was no obvious discomfort during treatment in the experimental group. One case of constipation and one case of dry mouth occurred in the control group, which were improved after patients were advised to increase dietary fiber intake and daily water intake, without drug withdrawal or special treatment. Conclusion Jiawei Xiaoyao Powder combined with Fluoxetine in the treatment of depression with liver stagnation and spleen deficiency is more effective than Fluoxetine alone, and has certain advantages in improving anxiety and depression, somatization discomfort and sleep quality, has high safety and is worthy of clinical promotion.
京公网安备 11010502046598号